Zobrazeno 41 - 50
of 245
pro vyhledávání: '"Patrick Arveux"'
Autor:
Patrick Arveux, P. Fumoleau, Florence Joly, Oumar Billa, Ariane Mamguem Kamga, Marie-Laure Poillot, Charles Coutant, Tienhan Sandrine Dabakuyo-Yonli, Ariane Darut-Jouve, Julien Simon, Agnes Dumas
Publikováno v:
Oncologist
Oncologist, AlphaMed Press, In press, pp.theoncologist.2018-0347. ⟨10.1634/theoncologist.2018-0347⟩
Oncologist, AlphaMed Press, In press, pp.theoncologist.2018-0347. ⟨10.1634/theoncologist.2018-0347⟩
BACKGROUND: The likelihood that health-related quality of life (HRQoL) could depend on factors other than clinical data increases with the duration of follow-up since diagnosis. The aim of this study was to identify determinants of long-term HRQoL in
Autor:
Jonathan Cottenet, Patrick Arveux, Catherine Quantin, Pascale Tubert-Bitter, Philippe Bonniaud, Alain Bernard, Lionel Piroth
Publikováno v:
Cancers
Cancers, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Volume 13
Issue 6
Cancers, MDPI, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Cancers, Vol 13, Iss 1436, p 1436 (2021)
Cancers, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Volume 13
Issue 6
Cancers, MDPI, 2021, 13 (6), pp.1-15. ⟨10.3390/cancers13061436⟩
Cancers, Vol 13, Iss 1436, p 1436 (2021)
(1) Background: Several smaller studies have shown that COVID-19 patients with cancer are at a significantly higher risk of death. Our objective was to compare patients hospitalized for COVID-19 with cancer to those without cancer using national data
Autor:
Patrick Arveux, Julien Simon, Catherine Quantin, Sonia Bechraoui-Quantin, Karine Goueslard, Jean-Michel Petit
Publikováno v:
Cancers, Vol 13, Iss 308, p 308 (2021)
Cancers
Volume 13
Issue 2
Cancers
Volume 13
Issue 2
The aim of this large retrospective cohort study was to use a quasi-exhaustive national medico-administrative database of deliveries in France to determine the risk of developing pancreatic cancer (PC) in women with a history of gestational diabetes
Autor:
Patrick Arveux, Ariane Mamguem Kamga, Ariane Darut-Jouve, Tienhan Sandrine Dabakuyo-Yonli, Sophie Marilier, Leila Bengrine-Lefevre, Isabelle Desmoulins, Laure Favier, Valérie Quipourt
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, BioMed Central, 2021, 19 (1), ⟨10.1186/s12955-021-01675-2⟩
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Health and Quality of Life Outcomes, BioMed Central, 2021, 19 (1), ⟨10.1186/s12955-021-01675-2⟩
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Background With the growing number of older endometrial cancer (EC) and ovarian cancer (OC) survivors, data on long-term health-related quality of life (HRQoL) became an important issue in the management of older patients. So, the aim of this study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ff44622c4a7125ff1b78beafd56d58
https://hal.archives-ouvertes.fr/hal-03487814
https://hal.archives-ouvertes.fr/hal-03487814
Publikováno v:
Revue medicale suisse. 16(713)
The new federal Act on registration of oncological diseases requires since January 1st 2020 institutions and treating physicians to transmit regulated data on all Swiss cancer cases and some precancerous pathologies to the competent tumour registry,
Autor:
Céline Charon-Barra, Corentin Richard, Laurent Arnould, Patrick Arveux, Hervé Bonnefoi, Françoise Beltjens, Catherine Loustalot, Emilie Degrolard-Courcet, Aurélie Bertaut, Anthony Bergeron, Gaëtan MacGrogan, Romain Boidot, Isabelle Desmoulins, Sophie Auriol, Sylvain Ladoire
Publikováno v:
Mod Pathol
Primary triple-negative invasive lobular breast carcinomas (TN-ILCs), which do not express hormone receptors and HER2 at diagnosis, are rare and poorly known. In this study, we analyzed the largest TN-ILC series ever reported in the literature, in co
Autor:
Léonor Fasse, Charles Coutant, Laurence Vanlemmens, A. Bardet, Arlindo R. Ferreira, Alexandra L. Dima, Angelo Paci, Agnès Dumas, Olivier Tredan, Florence Lerebours, Christelle Jouannaud, Fabrice Andre, Nan Lin, Patrick Soulié, Ann H. Partridge, Suzette Delaloge, Stefan Michiels, Ines Vaz-Luis, Gwenn Menvielle, Sandrine Pinto, Antonio Di Meglio, Barbara Pistilli, Sarah Dauchy, Anne Laure Martin, Paul Cottu, A. Lesur, Vianney Poinsignon, Sibille Everhard, Patrick Arveux, Christelle Levy
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (24), pp.2762-2772. ⟨10.1200/jco.19.01758⟩
JOURNAL OF CLINICAL ONCOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (24), pp.2762-2772. ⟨10.1200/jco.19.01758⟩
JOURNAL OF CLINICAL ONCOLOGY
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
PURPOSE Nonadherence to long-term treatments is often under-recognized by physicians and there is no gold standard for its assessment. In breast cancer, nonadherence to tamoxifen therapy after surgery constitutes a major obstacle to optimal outcomes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55818a757f6b7122431dfd41b246de0
https://hal.archives-ouvertes.fr/hal-03088682/document
https://hal.archives-ouvertes.fr/hal-03088682/document
Autor:
Patrick Arveux, Geneviève Jolimoy, Tienhan Sandrine Dabakuyo-Yonli, Agnès Dumas, Oumar Billa, Florence Joly, Julien Simon, Ariane Mamguem Kamga, Patrick Roignot, Charles Coutant, Marie-Laure Poillot
Publikováno v:
European Journal of Cancer Care. 29
Objective To describe socio-economic and professional outcomes in long-term survivors of cervical, endometrial or ovarian cancer, including return to work and problems related to obtaining loans and insurance. Methods Women with cervical, endometrial
Autor:
Charles Coutant, Agnès Dumas, Laurence Vanlemmens, Suzette Delaloge, Christelle Mesleard, Olivier Tredan, Gwenn Menvielle, Sandrine Pinto, Paul Cottu, Mayssam El Mouhebb, Jérôme Lemonnier, Cécile Charles, Thomas Bovagnet, A. Lesur, Sarah Dauchy, Fabrice Andre, Antonio Di Meglio, Patrick Arveux, Christelle Levy, Ines Maria Vaz Duarte Luis, Florence Lerebours
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (7), pp.734-743. ⟨10.1200/jco.19.01726⟩
Journal of Clinical Oncology, American Society of Clinical Oncology, 2020, 38 (7), pp.734-743. ⟨10.1200/jco.19.01726⟩
PURPOSE Adverse effects of breast cancer treatment can negatively affect survivors’ work ability. Previous reports lacked detailed clinical data or health-related patient-reported outcomes (PROs) and did not prospectively assess the combined impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8e9248494ef063680decfa22c4ba9d
https://hal.archives-ouvertes.fr/hal-03088680
https://hal.archives-ouvertes.fr/hal-03088680
Publikováno v:
Bulletin du cancer. 106(12S1)
Breast cancer, with 58,459 new cases in France in 2018, is the most common cancer among women. Breast cancer, of young women, defined by consensus as women under 40 years of age, represents only 5% of breast cancer cases in France and 7% worldwide. E